Background In recent decades, there has been a considerable increase in the number of
nanomedicine-based formulations, and their advantages, including controlled/targeted drug …

Cancer is a leading cause of death throughout the world, and cancer therapy remains a big
medical challenge in terms of both its therapeutic efficacy and safety. Therefore, to find out a …

Fenofibrate (FF) is a common lipid-lowering drug and a potent agonist of the peroxisome
proliferator-activated receptor alpha (PPARα). FF and several other agonists of PPARα have …

Fenofibrate is a third-generation fibric acid derivative indicated as a monotherapy to reduce
elevated low-density lipoprotein cholesterol, total cholesterol, triglycerides, and …

Since their inception in the early 1960s, the development and use of nanoscale materials
have progressed tremendously, and their roles in diverse fields ranging from human health …

This study evaluated the effects of flavonoids from mulberry leaves (FML) on plasma
biochemical indices, serum activities of lipid metabolism-related enzymes, fat morphology …

The understanding of drug biotransformation is an important medical topic. The oxidative
pathways that involve CYPs have been extensively studied in drug metabolism in contrast to …

Fenofibrate, a peroxisome proliferator‐activated receptor alpha (PPARα) agonist and lipid‐
lowering agent, has been used worldwide for treatment of hyperlipidemia. The clinical trials …

Essential oil components from turmeric (Curcuma longa L.) are documented for
neuroprotective, anti-cancer, anti-thrombotic and antioxidant effects. The present study …

Fenofibrate is a safe and inexpensive orally administered fibric acid derivative
conventionally used to treat dyslipidemia. Two large randomized clinical trials, the …